Biocryst Pharmaceuticals buy Needham & Company LLC

Summary

This prediction ended on 21.04.24 with a price of €4.10. The BUY prediction by Needham___Company_LL for Biocryst Pharmaceuticals performed very badly with a performance of -38.50%. Needham___Company_LL has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Needham___Company_LL has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y	3y
Biocryst Pharmaceuticals	-11.301%	-11.301%	9.469%	26.971%
iShares Core DAX®	-1,11 %	-0,85 %	2,02 %	51,34 %
iShares Nasdaq 100	-4,35 %	-5,76 %	26,25 %	78,91 %
iShares Nikkei 225®	-6,79 %	-10,34 %	53,21 %	67,90 %
iShares S&P 500	-1,79 %	-0,33 %	21,46 %	65,97 %